0001972649-23-000003.txt : 20231003 0001972649-23-000003.hdr.sgml : 20231003 20231003164811 ACCESSION NUMBER: 0001972649-23-000003 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EAGLE PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000827871 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36306 FILM NUMBER: 231304774 BUSINESS ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-326-5300 MAIL ADDRESS: STREET 1: 50 TICE BOULEVARD, SUITE 315 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: EAGLE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19880120 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Tarriff Scott CENTRAL INDEX KEY: 0001469124 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 28 TUDOR ROSE TERRACE CITY: MAHWAH STATE: NJ ZIP: 07430 144 1 primary_doc.xml 144 0001469124 XXXXXXXX LIVE 0000827871 EAGLE PHARMACEUTICALS, INC. 001-36306 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300 Tarriff Scott CEO and President Common Janney Montgomery Scott LLC

1717 Arch Street Philadelphia PA 19101

10734 155000.00 12986971 10/03/2023 NASDAQ Common 01/23/2019 Executive Compensation Issuer N 5028 01/23/2019 Cash Common 01/05/2020 Executive Compensation Issuer N 5706 01/05/2020 Cash N SCOTT TARRIFF

1000 WEST AVE APT TS1 MIAMI BEACH FL 33139

Common 10/02/2023 9511 144856.08 Trades were made pursuant to a 10b5-1 trading plan. 10/03/2023 06/15/2023 Scott Tarriff